Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Share-based Compensation (2016 - 2025)

Macrogenics (MGNX) has disclosed Share-based Compensation for 14 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 76.38% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.3 million through Dec 2025, down 51.47% year-over-year, with the annual reading at $14.3 million for FY2025, 51.47% down from the prior year.
  • Share-based Compensation for Q4 2025 was $2.7 million at Macrogenics, down from $3.5 million in the prior quarter.
  • The five-year high for Share-based Compensation was $11.3 million in Q4 2024, with the low at $2.7 million in Q4 2025.
  • Average Share-based Compensation over 5 years is $5.3 million, with a median of $5.2 million recorded in 2022.
  • The sharpest move saw Share-based Compensation surged 158.43% in 2024, then tumbled 76.38% in 2025.
  • Over 5 years, Share-based Compensation stood at $5.4 million in 2021, then decreased by 12.4% to $4.7 million in 2022, then dropped by 8.06% to $4.4 million in 2023, then surged by 158.43% to $11.3 million in 2024, then crashed by 76.38% to $2.7 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $2.7 million, $3.5 million, and $3.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.